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debranching for complex aortic aneurysm repair
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Objective: This study reports our initial experience with the Gore Hybrid Vascular Graft (GHVG; W. L. Gore & Asso-
ciates, Flagstaff, Ariz) for staged hybrid open renovisceral debranching and endovascular aneurysm repair in patients
affected by thoracoabdominal aortic aneurysms and pararenal abdominal aortic aneurysms (PAAAs).
Methods: Between December 2012 and December 2013, we analyzed outcomes of 13 patients who underwent open
surgical debranching of renovisceral vessels for thoracoabdominal aortic aneurysm and PAAAs. All patients were
considered at high risk for conventional surgery. Inclusion criterion was treatment by open surgical debranching of at
least one visceral artery (renal artery, superior mesenteric artery [SMA], or celiac trunk [CT]) using the GHVG. In a
second step, the aortic stent graft was implanted to exclude the aneurysm. If required, parallel grafts to the remaining
visceral arteries were deployed in the same procedure. One patient had a symptomatic descending thoracic aortic aneu-
rysm and another had a ruptured PAAA. Perioperative measured outcomes were immediate technical success rate,
mortality, and morbidity. Median follow-up was 24.8 months (range, 0-15; mean, 8.2; standard deviation, 4 months).
Results: All open surgical debranching of renovisceral vessels were completed as intended. GHVG was used to revascu-
larize 20 visceral vessels in 13 patients with a mean of 1.54 vessels per patient. Six renal arteries (30%; 2 right and 4 left), 9
SMAs (45%), and 5 CTs (25%) were debranched. In nine of 13 (66%) patients, other renovisceral arteries were addressed
with chimney/periscope, Viabahn Open Revascularization Technique, and end-to-side anastomosis. Two of 13 patients
(15%) died of bowel ischemia. Neither patient had GHVG revascularization to the SMA or CT. Perioperative compli-
cations occurred in three patients (23%; 1 renal hematoma, 1 respiratory insufﬁciency, and 1 small-bowel ischemia related
to a SMA GHVG thrombosis). At 24 months, estimated survival was 85%, and estimated primary and secondary patency
were 94% and 100%, respectively.
Conclusions: This limited series extracted from a more consistent hybrid procedure experience showed a mortality rate
similar to most recent reports. Technical feasibility and the short-term patency rate of the GHVG for renovisceral
debranching during staged hybrid open and endovascular procedures were satisfactory. Use of GHVGs may represent a
useful revascularization adjunct to minimize visceral ischemia in these challenging patients. (J Vasc Surg 2016;64:33-8.)The total endovascular repair of thoracoabdominal
aortic aneurysm (TAAAs) and pararenal AAA (PAAAs) rep-
resents a hugely appealing less invasive approach. Major re-
strictions limiting its use are the anatomic requirements,
the need for customized devices resulting in treatment
delay, and the complex device sizing and procedural plan-
ning.1-3 Therefore, there are subsets of patients that are
considered unﬁt for traditional open aortic repair due to
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ovisceral debranching and the endovascular aneurysm
exclusion, can bridge the gap between these two options,
being readily available and reproducible.4,5
Despite the initial enthusiasm for the hybrid repair
(HR),6,7 several series reported a 30-day mortality rates
of 13% to 23%, which are similar to the outcomes after
traditional open surgical repair.8,9 Most of the HR mortal-
ity was related to renovisceral dysfunctions. Although
several factors are supposed to be involved in such dysfunc-
tion, the most important is deﬁnitely the ischemia time
during the arterial anastomosis.10
To reduce the renovisceral ischemia during multiple
bypasses, a novel tool with sutureless endovascular anasto-
mosis11 was developed to allow a decreasing ischemic time
during sequential bypass. Subsequently, with the same
rationale grew up the Gore Hybrid Vascular Graft
(GHVG; W. L. Gore and Associates, Flagstaff, Ariz), which
is a novel expanded polytetraﬂuoroethylene (ePTFE)
vascular prosthesis that includes a nitinol reinforced
self-expanding section at one extremity that allows a
“sutureless” endovascular anastomosis. The present study
reports our initial experience with the GHVG used during
renovisceral debranching in patients affected by TAAAs
and PAAAs.33
Table. Demographics and comorbidities
Variable Mean 6 SD or No. (N ¼ 13)
Age, years 70 6 8
Male gender 8
Hypertension 13
Diabetes 2
Lipid disorder 9
COPD 5
Renal function impairment 5
Coronary disease 4
ASA class 3 or 4 12
Peripheral arterial disease 4
Hostile chest 5
Hostile abdomen 5
PAAA 5
TAAA (Crawford I) 4
DTAA 1
Arch to visceral AA 3
AA, Aortic aneurysm; ASA, American Society of Anesthesiologists; COPD,
chronic obstructive pulmonary disease; DTAA, descending thoracic aortic
aneurysm; PAAA, pararenal abdominal aortic aneurysm; SD, standard de-
viation; TAAA, thoracoabdominal aortic aneurysm.
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Data from patients affected by TAAAs and PAAAs,
treated with staged hybrid open and endovascular renovisc-
eral debranching and endovascular aneurysm repair
(EVAR), were prospectively collected from January 2013
to March 2014, into the clinical information system
(Dendrite and KISIM 4.901; Dendrite Clinical Systems,
Ltd, Henley-on-Thames, United Kingdom) of our institu-
tion. Informed consent for the procedure itself and for the
anonymous data collection and analysis was obtained from
all patients. The Institutional Review Board approved the
retrospective study.
All included patients were considered at high risk for
conventional surgery. Inclusion criterion was the treatment
by open surgical debranching of at least one visceral artery
(renal artery [RA], superior mesenteric artery [SMA], or
celiac trunk [CT]) using the GHVC. Patients who required
debranching of the internal iliac arteries and supra-aortic
vessels were excluded, as were patients with obstructive
aortic pathologies. Aneurysmatic aortic pathology was
deﬁned according reporting standards.12,13
The perioperative outcomes were immediate technical
success rate, morbidity, and mortality. Immediate technical
success was deﬁned as the procedure being completed as
intended. Intensive care unit length of stay (LOS), intuba-
tion duration, in-hospital LOS were also analyzed. Survival,
primary patency, and secondary patency were estimated.
Adjunctive procedures related to visceral debranching
during follow-up were recorded with their related out-
comes (immediate technical success rate, perioperative
mortality, and morbidity). Follow-up was calculated from
the visceral debranching intervention. The follow-up pro-
tocol consisted of computed tomography angiography, lab-
oratory testing, and clinical examination at 6 weeks, 3 and
6 months later, and yearly thereafter. Patients presenting
with renal function impairment were monitored by native
computed tomography and duplex ultrasound imaging of
the aorta and target vessels.
Data analysis was performed using SPSS 16.0 software
(IBM Corp, Armonk, NY). Mean and standard deviations
(SDs) are reported for parametric data and absolute values
and range for nonparametric data. Statistical signiﬁcance
was assigned at a two-sided P of <.05. Kaplan-Meier curves
were used to estimate survival and patency. Median
follow-up was 24.8 months (range, 0-15; mean, 8.2; SD,
4 months).
RESULTS
A total of 13 patients meet the inclusion criteria and
were included in the study. Demographic and comorbid-
ities are reported in the Table. Procedures were elective
in 11 patients (85%) and nonelective in two (15%). One
of these patients had a symptomatic descending thoracic
aortic aneurysm and the remaining was a ruptured PAAA.
The GHVG was used for 20 visceral vessels, with a mean
of 1.54 vessels per patients. Six RAs (30%; 2 right and
4 left), 9 SMAs (45%), and 5 CTs (25%) were debranched.Additional visceral vessels were addressed in nine (69%) of
these patients with chimney/periscope graft14,15
(13 vessels), Viabahn Open Revascularization Technique16
(2 vessels), and end-to-side anastomosis (2 vessels; Fig 1).
Immediate technical success was achieved in all cases.
Perioperative mortality was 15% (2 patients). One death
occurred on postoperative day (POD) 2 caused by bowel
ischemia and multiorgan failure secondary to multiple
embolization. The SMA and CT were not debranched in
this patient. The other perioperative death, on POD 18,
was caused by bowel ischemia due to acute SMA occlusion.
The SMA in this patient was addressed with an end-to-side
anastomosis.
Perioperative complications occurred in three patients
(23%), consisting in one patient each of renal hematoma
(chimney/periscope related), respiratory insufﬁciency
requiring prolonged intubation, and small bowel ischemia
due to a GHVG thrombosis in the SMA. Mean intensive
care unit LOS was 2.5 days (range, 0-9; SD, 3 days), intu-
bation duration was 1.4 days (range, 0-6; SD, 2 days), and
in-hospital LOS was 12 days (range, 2-35; SD, 10 days).
One adjunctive maneuver was performed in the patient
who presented with small bowel ischemia caused by
SMA-GHVG occlusion. The GHVG bypass occlusion
was managed successfully by endovascular locoregional
lysis. Estimated survival at 6 months was 85%. The
estimated primary and secondary patency was 95% and
100%, respectively. Survival and patency curves are
depicted in Figs 2 and 3, respectively.
Debranching in 11 patients (85%) was followed by
EVAR. EVAR was not performed in the remaining two
patients due to death on PODs 2 and 18. The mean inter-
val from visceral debranching with GHVG to aneurysm
exclusion with EVAR was 2.5 months (range, 0-5; SD,
2 months). Both nonelective procedures were performed
consecutively.
Fig 1. Intraoperative picture shows the proximal anastomosis of
the Gore Hybrid Vascular Graft (GHG; W. L Gore and Associates,
Flagstaff, Ariz) to the superior mesenteric artery (SMA) and the
Viabahn Open Revascularization Technique (VORTEC) anasto-
mosis to the celiac trunk (CT).
JOURNAL OF VASCULAR SURGERY
Volume 64, Number 1 Setacci et al 35
Author's Personal CopyDISCUSSION
Conﬂicting results of hybrid debranching strategy for
TAAA and PAAA treatment led to criticism and ambiguity
of this approach, despite initial enthusiasm.17,18 The
systematic review by Moulakakis et al19 analyzed 19 publi-
cations comprising 507 patients who underwent HR. This
review reported a primary technical success of 96.2% (95%
conﬁdence interval [CI], 93.5%-98.2%) and visceral graft
patency of 96.5% (95% CI, 95.2%-97.8%). The same report
observed a pooled rate of 7.5% (95% CI, 5.0%-11.0%) for
overall spinal cord ischemia symptoms, with an irreversible
paraplegia rate of 4.5% (95% CI, 2.5%-7.0%). The pooled
30-day/in-hospital mortality rate was 12.8% (95% CI,
8.6%-17.0%). Despite these reported outcomes, the HR
has demonstrated better results in some centers.20
One of the most important issues related to the high
mortality rate of the HR technique is that this operation
remains technically demanding because of the extensive
aortic exposure and prolonged interruption of aortic ﬂow
to the visceral branches. During the last decades, several
new technical improvements focused attention on the
reduction of ischemic time during the renovisceral anasto-
mosis to reduce the risk of bowel ischemia and the global
procedure time.
In our experience, since 2007, covered self-expanding
stents are being used to perform “sutureless anastomoses”
on renovisceral aortic branches during debranching proce-
dures. This tool obviated the need for technically
demanding vessel exposure and anastomoses, thereby
reducing the duration of ﬂow interruption and simplifying
the performance of complex aortic repair.During this time, the original Viabahn Open Revascu-
larization Technique, with the transection of the target
vessel, has been modiﬁed. The novel technique consists
of placement of the Viabahn self expanding stent graft
(W. L. Gore and Associates) in a Seldinger technique
into the visceral arteries after surgical identiﬁcation of the
origin of these arteries.21 Brieﬂy, the Viabahn stent graft
is passed through an ePTFE vascular graft, the visceral arte-
rial wall is punctured, and a standard wire is placed. The
Viabahn is then advanced (w2.5 cm) over the wire into
the visceral artery, the vascular graft is placed against the
arterial wall, and the stent graft is deployed. A balloon is
inﬂated corresponding to the Viabahn that is positioned
for half-length inside the artery and half-length inside the
vascular graft. Finally, the arterial wall, the stent graft,
and the vascular graft are ﬁxed with a couple of stitches
with Prolene (Ethicon, Somerville, NJ).
This modiﬁcation already determined a reduced
ischemic time from 11 minutes to <1 minute to perform
a visceral anastomosis. The GHVG represents the natural
evolution of this procedure, allowing a signiﬁcant reduc-
tion of the global procedural time by using a single graft.
The tubular heparin-bonded ePTFE graft is preconnected
to the nitinol stent-reinforced section, guaranteeing
in-line ﬂow and avoiding ﬂow turbulence. The device was
released by Gore in 2012 in the European market and
approved for hemodialysis access, lower limb bypass
grafting, aortic arch debranching, and visceral
revascularization.22
Bornak et al23 reported the ﬁrst case of sutureless
visceral artery revascularization using the GHVG in 2012.
They described the treatment of a symptomatic TAAA
involving the visceral segment and an infrarenal AAA.
The patient was treated in a two-staged hybrid approach
combining an endovascular repair of the infrarenal
segment, followed by an open thoracic aortic aneurysm
repair. The large visceral arteries were revascularized using
GHVG and a gradual funneling technique with Dacron
(DuPont, Wilmington, Del).
After this ﬁrst reported patient, excluding the literature
regarding hemodialysis access, two authors reported
patients treated with GHVG in different aortic
segments24,25 or in other districts.26-28 The ﬁrst large expe-
rience with the use of GHVG was recently reported by
Chiesa et al29 to address RAs during open TAAA repair.
Their experience with 25 patients reported satisfactory
results that are at least comparable to those of standard
renal revascularization. This was the ﬁrst study reporting
GHVG outcomes in renovisceral debranching during
TAAAs and PAAAs HR.
More recently Tsilimparis et al30 reported their
experience in 12 patients presenting challenging aortic
disease and addressed with the GHVG in renovisceral
arteries. In this series, with a median follow-up of
12 months, GHVG patency was 96%; moreover, using
the GHVS resulted in a signiﬁcant reduction of the time
to perform the anastomosis compared with the standard
anastomosis.
Fig 3. Estimated primary and secondary patency. The standard error is<10% at 24month for primary and secondary patency.
Fig 2. Estimated survival. The standard error is >10% at 1 month.
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technique was technically feasible in all the planned proce-
dures, irrespective of renovisceral vessels anatomic location
and quality, with good midterm results. In our reported
experience, two patients died of bowel ischemia. The
causes of death were due to multiple embolization in the
ﬁrst patient and to acute SMA occlusion in the second. It
is important to note that only one RA was addressed in
the ﬁrst patient, and the SMA was revascularized in the sec-
ond patient without GHVG but with end-to-side
anastomosis.
At a median follow-up of 24.77 months, we reported
one adjunctive procedure due to a GHVG-to-SMA occlu-
sion that was successfully managed with locoregional lysis.
CONCLUSIONS
This limited series has to be considered, together with
important limitations related to the small number of cases.
However, technical feasibility and short-term patency rate
of the GHVG for renovisceral debranching during staged
hybrid open and endovascular procedures were satisfactory.
This novel graft will represent an additional step forward in
the challenge of perioperative visceral ischemia, allowing
faster procedures. The midterm results are very promising,
especially considering that this treatment option is chosen
in patients considered unﬁt or at high-risk for conventional
surgery or inappropriate for fenestrated/branched EVAR.
If long-term results remain good, this method could be
an attractive alternative to open surgery or fenestrated/
branched EVAR in selected patients.
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